I agree with you and Flip on the overall picture and the company strategy. It is a multi-pronged approach aimed at manufacturing capability, approval strategy, and the TLD release.
I’m not disagreeing, so I just want to ask you what happens if the other steps have been met but one is delayed, how do you bring them to fruition at the same time without delaying unveiling a multitude of steps? Even if one step is their highest priority and ready, wouldn’t it be delayed by another delayed step?
I thnk they have likely been doing everything they can on each step, some out of order so probably not as much as one would like when things are out of order. Additionally, I believe they could not give a timeline because some things are in fact, my opinion, dependent upon certain regulatory authorities finalizing and completing their own internal work which is not specific to DCVax, but impacts it. Just my opinion.
Market Data 
Markets 
AI
